文献速递白血病

抑制Slug通过Slc13a3/ROS信号通路有效靶向白血病干细胞

Inhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway.
PubMed 文献 · Leukemia · 2019-09-06

该研究探讨锌指转录抑制因子Slug在急性髓系白血病(AML)中的作用,发现Slug促进白血病发生,其缺失损害白血病干细胞(LSC)自我更新并延缓白血病进展。机制上,Slc13a3是Slug在LSC中的直接靶点,限制LSC自我更新并显著延长受体生存。遗传或药理抑制SLUG或强制表达Slc13a3可抑制人AML细胞生长,提示Slug和Slc13a3是潜在LSC治疗靶点。

要点

  • Slug促进AML发生并维持LSC自我更新。
  • Slc13a3是Slug在LSC中的直接靶点,限制LSC自我更新。
  • 靶向SLUG或上调Slc13a3可抑制人AML细胞生长。

核心结论

  • Slug差异调控LSC与正常造血干细胞的自我更新,Slug和Slc13a3均为潜在LSC治疗靶点。

研究设计与样本

  • 基于Leukemia发表的实验研究,使用遗传和药理手段在AML模型中研究Slug功能。

主要发现

  • Slug缺失损害LSC自我更新并延缓白血病进展。
  • Slc13a3是Slug在LSC中的直接靶点,限制LSC自我更新并显著延长受体生存。
  • 遗传或药理抑制SLUG或强制表达Slc13a3抑制人AML细胞生长。

临床怎么用

  • Slug和Slc13a3可作为靶向LSC、预防AML复发的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Leukemia stem cells (LSCs) are the rare populations of acute myeloid leukemia (AML) cells that are able to initiate, maintain, and propagate AML. Targeting LSCs is a promising approach for preventing AML relapse and improving long-term outcomes. While Slug, a zinc-finger transcription repressor, negatively regulates the self-renewal of normal hematopoietic stem cells, its functions in AML are still unknown. We report here that Slug promotes leukemogenesis and its loss impairs LSC self-renewal and delays leukemia progression. Mechanistically, Slc13a3, a direct target of Slug in LSCs, restricts the self-renewal of LSCs and markedly prolongs recipient survival. Genetic or pharmacological inhibition of SLUG or forced expression of Slc13a3 suppresses the growth of human AML cells. In conclusion, our studies demonstrate that Slug differentially regulates self-renewal of LSCs and normal HSCs, and both Slug and Slc13a3 are potential therapeutic targets of LSCs.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Li L, Wu C, et al. Inhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway. Leukemia. 2019. PMID: 31492896. doi:10.1038/s41375-019-0566-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。